newsfilter
← Latest News
PR Newswire·

Seelos Therapeutics Announces Business Update on its Key Programs

NEW YORK, March 29, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders